COVID-19 illness: Different comorbidities may require different immunological therapeutic targets.
Elisa GremeseBarbara TolussoDario BrunoAnna Maria PaglionicoSimone PerniolaGianfranco FerraccioliStefano AliverniniPublished in: European journal of clinical investigation (2023)
Herein, we discuss the biological background associated with distinct comorbidities which might impact the SARS-CoV-2 infection course and how these should to be addressed to improve the current therapeutic outcome.